TFOS Lifestyle: Impact of cosmetics on the ocular surface

DA Sullivan, AX da Costa, E Del Duca, T Doll… - The Ocular Surface, 2023 - Elsevier
In this report the use of eye cosmetic products and procedures and how this represents a
lifestyle challenge that may exacerbate or promote the development of ocular surface and …

[HTML][HTML] Topical glaucoma medications–clinical implications for the ocular surface

F Fineide, N Lagali, MY Adil, R Arita, M Kolko, J Vehof… - The ocular …, 2022 - Elsevier
Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to
reduce intraocular pressure remains the mainstay treatment. These eye drops frequently …

Advances in biodegradable nano-sized polymer-based ocular drug delivery

C Lynch, PPD Kondiah, YE Choonara, LC du Toit… - Polymers, 2019 - mdpi.com
The effective delivery of drugs to the eye remains a challenge. The eye has a myriad of
defense systems and physiological barriers that leaves ocular drug delivery systems with …

How do different lighting conditions affect the vision and quality of life of people with glaucoma? A systematic review

J Enoch, L Jones, DJ Taylor, C Bronze, JF Kirwan… - Eye, 2020 - nature.com
This article is a systematic review of evidence regarding the impact of different lighting
conditions on the vision and quality of life (QoL) of people with primary open-angle …

Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: the VISIONARY study

F Oddone, L Tanga, P Kóthy, G Holló - Advances in Therapy, 2020 - Springer
Introduction A non-interventional, multicenter, European, prospective evaluation of the
effectiveness, tolerability, and safety of a topical preservative-free tafluprost (0.0015%) and …

Glaucoma medication and quality of life after phacoemulsification combined with a Xen gel stent

C Pahljina, S Sarny, L Hoeflechner, T Falb… - Journal of Clinical …, 2022 - mdpi.com
Glaucoma has a significant impact on quality of life. Here, we aimed to evaluate the
influence of a reduction in glaucoma medications on quality of life and patient satisfaction …

Improving adherence to topical medication in patients with glaucoma

I Tapply, DC Broadway - Patient preference and adherence, 2021 - Taylor & Francis
The glaucomas form a heterogenous group of conditions, which collectively account for one
of the most common irreversible causes of blindness worldwide. The only treatment, for …

Ocular surface disease in glaucoma patients

C Scelfo, RH ElSheikh, MM Shamim… - Current eye …, 2023 - Taylor & Francis
Purpose To review the most recent studies in the literature regarding the ocular surface in
glaucoma patients and treatment options aimed to reduce ocular surface disease in this …

Role of Biodegradable Polymers in Ocular Drug Delivery

P Pingale, K Pardeshi, A Rajput - Handbook of Biodegradable …, 2025 - taylorfrancis.com
Biodegradable polymers are a unique class of biomaterials with a wide range of medical,
biological, and pharmacological purposes. The word “biomaterials” was coined in 1982 at …

Comparison of adherence between fixed and unfixed topical combination glaucoma therapies using Japanese healthcare/pharmacy claims database: a retrospective …

C Shirai, N Matsuoka, T Nakazawa - BMC ophthalmology, 2021 - Springer
Background Adherence to chronic therapies is crucial to prevent the progression of disease,
such as glaucoma. However, only a limited number of studies have investigated them using …